News and Comments

Good News for Agenus and for Global Blood Therapeutics

  Friday, June 10, 2016

Agenus (AGEN) announced that a lead product candidate is selected under its license and research collaboration with Merck, which is known as MSD outside the United States and Canada.   More...

COULD AGENUS VACCINE FOR GLIOBLASTOMA BE ASSIGNED BREAKTHROUGH DESIGNATION?

  Tuesday, September 17, 2013

AGENUS (AGEN) has extraordinary news. A recent analysis from a Phase 2 trial in patients with newly diagnosed glioblastoma multiforme (GBM) treated with Prophage Series G-100 (HSPPC-96) in combination with the current standard of care (radiation and temozolomide) showed an almost 18 month median progression free survival (PFS), which represents a 160% increase versus current standard of care alone. The results confirm continuation of the positive trends from the Phase 2 HSPPC-96 newly diagnosed GBM trial first reported at the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in May 2013. More...


Recent Postings


Archive


Tags

Pluristem (PSTI) Mirati Therapeutics (MRTX) Anacor (ANAC) CEMPRA (CEMP) Onyx (ONXX) Genentech OncoCyte (OCX) Benlysta (belimumab) Rapamune JUNO (JUNO) Theravance (THRX) Alnylam (ALNY) Ziofpharm (ZIOP) SUNESIS PHARMACEUTICALS (SNSS) Human Genome Sciences (HGSI) Velcade (bortezomib) Theravance Bio Pharma (TBPH) PTC Therapeutics (PTCT) Multiple Myeloma Ocular Therapeutix (OCUL) AERIE PHARMACEUTICALS Elan (ELN) NANTKWEST (NK) MODERNA Intrexon (XON) Telaprevir Trastuzumab-DM1 Agenus (AGEN CRISPR Therapeutics (CRSP) Sarepta (SRPT) ImmunoGen (IMGN) Roche (RHHBY) ZALTRAP™ Endometrial Cancer Valeant Pharmaceuticals International (VRX) Ridaforolimus GUARDIAN HEALTH Bristol-Myers Squibb (BMY) Vertex (VRTX) Prosensa (RNA) ARCA (ABIO) REGULUS (RGLS) PORTOLA (PTLA) Editas (EDIT) Ariad (ARIA) Inovio (INO) Revlimid (lenolidamide) Roche (ROCHE) Sanofi-Aventis (SAN) ABBVIE (ABBV) Prolor Biotech (PBTH) Ionis (IONS) Advaxis (ADXS) Intermune (ITMN) Tysabri Dendreon (DNDN) ARGOS (ARGS) KITE (KITE) INNOVIVA (INVA) Intercept (ICPT) Xoma (XOMA) IDERA (IDRA) Cytokinetics (CYTK) Regeneron (REGN) Herceptin Human Longevity (HLI) Biocryst (BCRX) NEKTAR (NKTR)) AGOS (ARGS) galapagos (GLPG) JOUNCE THERAPEUTICS (JNCE) Global Cell Therapeutics (GBT) Array Pharmaceuticals (ARRY) OSI (OSIP) ACADIA (ACAD) Sanofi (SNA) Idenix (IDIX) VANDA (VNDA) Amgen (AMGN) ISIS (ISIS) Dynavax (DVAX) LEXICON (LXRX) Abbott Laboratories (ABT) Zerenex Agenus (AGEN) Sequenom (SQNM) Aimmune Therapeutics (AIMT) Auspex (ASPX) C4 Therapeutics Merck (MRK) SYNTA (SNTA) Micromet (MITI) RenenxBio (RGNX) Seattle Genetics (SGEN) ADVENTRIX (ANX) TOKAI (TKAOI) CompuGen (CGEN) Sangamo (SGMO) Bellicum (BLCM) HALOZYME (HALO) Jazz Pharmaceuticals (JAZZ) Galena (GALE) Gilead (GILD) Exelixis (EXEL) Anadys (ANDS) Illumina (ILMN) BIOMARIN (BMRN) Alder Biopharmaceuticals (ALDR) AstraZeneca (AZN) GlaxoSmithKline (GSK) SERES THERAPEUTICS (MCRB) Biogen Idec (BIIB) Sanofi (SNY) NOVOCURE (NVCR) Spike Therapeutics (ONCE) Incyte (INCY) Adaptimmune (ADAP) Vitae Pharmaceuticals (VTAE) KERYX (KERX)